Tonic and phasic release of glutamate and acetylcholine neurotransmission in sub-regions of the rat prefrontal cortex using enzyme-based microelectrode arrays

The medial prefrontal cortex (mPFC) is an area of the brain critical for higher cognitive processes and implicated in disorders of the CNS such as drug addiction, depression and schizophrenia. Glutamate and acetylcholine are neurotransmitters that are essential for cortical functioning, yet little is known about the dynamic function of these neurotransmitters in subregions of the mPFC. In these studies we used a novel microelectrode array technology to measure resting levels (tonic release) of glutamate and acetylcholine as well as KCl-evoked release (stimulated phasic release) in the mPFC of the anesthetized rat to further our understanding of both tonic and phasic neurotransmission in the cingulate cortex, prelimbic cortex, and infralimbic cortex of the mPFC. Studies revealed homogeneity of tonic and phasic signaling among brain subregions for each neurotransmitter. However, resting levels of glutamate were significantly higher as compared to acetylcholine levels in all subregions. Additionally, KCl-evoked acetylcholine release in the cingulate cortex (7.1 μM) was significantly greater than KCl-evoked glutamate release in any of the three subregions (Cg1, 2.9 μM; PrL, 2.0 μM; IL, 1.8 μM). Interestingly, the time for signal decay following KCl-evoked acetylcholine release was significantly longer by an average of 240% as compared to KCL-evoked glutamate release for all three brain subregions. Finally, we observed a negative relationship between acetylcholine resting levels and KCl-evoked release in the Cg1. These data suggest a homogenous distribution of both glutamatergic and acetylcholinergic innervation in the mPFC, with alterations in tonic and phasic release regulation accounting for differences between these neurotransmitters.

[1]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[2]  R. Nirogi,et al.  Quantification of acetylcholine, an essential neurotransmitter, in brain microdialysis samples by liquid chromatography mass spectrometry. , 2010, Biomedical chromatography : BMC.

[3]  H. Lawler Turnover time of acetylcholinesterase. , 1961, The Journal of biological chemistry.

[4]  B. Dean,et al.  Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. , 2001, The American journal of psychiatry.

[5]  T. Cassano,et al.  Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study. , 2007, Pharmacological research.

[6]  F. Pomerleau,et al.  Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fischer 344 rats , 2004, Journal of Neural Transmission.

[7]  Jason M. Williams,et al.  Cocaine increases medial prefrontal cortical glutamate overflow in cocaine‐sensitized rats: a time course study , 2004, The European journal of neuroscience.

[8]  M. Wolf,et al.  Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex , 1999, The European journal of neuroscience.

[9]  G. Gerhardt,et al.  In vivo electrochemical studies of monoamine release in the medial prefrontal cortex of the rat , 1989, Neuroscience.

[10]  H. Meltzer,et al.  The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: Potentiation of risperidone-, but not haloperidol-, induced dopamine efflux , 2007, Brain Research.

[11]  Francois Pomerleau,et al.  Ceramic-based multisite microelectrode arrays for simultaneous measures of choline and acetylcholine in CNS. , 2008, Biosensors & bioelectronics.

[12]  J. Homberg,et al.  Effect of amphetamine on extracellular acetylcholine and monoamine levels in subterritories of the rat medial prefrontal cortex. , 2000, European journal of pharmacology.

[13]  G. Gerhardt,et al.  Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. , 2001, Analytical chemistry.

[14]  M. Sofuoglu,et al.  Cholinergic Functioning in Stimulant Addiction , 2009, CNS drugs.

[15]  Koji Hara,et al.  Anesthetic Pharmacology International Society for Anaesthetic Pharmacology the Anesthetic Mechanism of Urethane: the Effects on Neurotransmitter-gated Ion Channels , 2022 .

[16]  K. Moxon,et al.  Ceramic-based multisite microelectrodes for electrochemical recordings. , 2000, Analytical chemistry.

[17]  N. Rüsch,et al.  Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[18]  A. Crane,et al.  Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates , 1979, Brain Research.

[19]  R. Schwarcz,et al.  Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release , 2009, The European journal of neuroscience.

[20]  M. Sarter,et al.  Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats , 2003, Psychopharmacology.

[21]  M. Sarter,et al.  Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. , 1996, Behavioral neuroscience.

[22]  P. E. Gold,et al.  Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. E. Vaughn,et al.  Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: A study of cholinergic neurons and synapses , 1985, The Journal of comparative neurology.

[24]  T. Jay,et al.  Anatomical and Electrophysiological Evidence for an Excitatory Amino Acid Pathway from the Thalamic Mediodorsal Nucleus to the Prefrontal Cortex in the Rat , 1994, The European journal of neuroscience.

[25]  G. Gerhardt,et al.  Microelectrode array studies of basal and potassium‐evoked release of l‐glutamate in the anesthetized rat brain , 2006, Journal of neurochemistry.

[26]  J. Meador-Woodruff,et al.  Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia , 2008, Schizophrenia Research.

[27]  F. Mora,et al.  Stress, prefrontal cortex and environmental enrichment: Studies on dopamine and acetylcholine release and working memory performance in rats , 2007, Behavioural Brain Research.

[28]  Microdialysis without acetylcholinesterase inhibition reveals an age-related attenuation in stimulated cortical acetylcholine release , 2003, Neurobiology of Aging.

[29]  G. Gerhardt,et al.  Regional effects of aging on dopaminergic function in the Fischer-344 rat , 1992, Neurobiology of Aging.

[30]  T. Woo,et al.  Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia , 2008, Brain Research.

[31]  Martin Sarter,et al.  Cortical cholinergic transmission and cortical information processing in schizophrenia. , 2005, Schizophrenia bulletin.

[32]  Francois Pomerleau,et al.  Chronic second‐by‐second measures of l‐glutamate in the central nervous system of freely moving rats , 2007, Journal of neurochemistry.

[33]  A. Delacourte,et al.  Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease , 2008, Neurobiology of Aging.

[34]  M. Mesulam,et al.  Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6) , 1983, Neuroscience.

[35]  Pradyot Nandi,et al.  Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. , 2009, Analytica chimica acta.

[36]  B. Westerink,et al.  Brain microdialysis of GABA and glutamate: What does it signify? , 1997, Synapse.

[37]  C. Leonard,et al.  The prefrontal cortex of the rat. I. Cortical projection of the mediodorsal nucleus. II. Efferent connections. , 1969, Brain research.

[38]  U. Ungerstedt,et al.  A dual probe characterization of dialysate amino acid levels in the medial prefrontal cortex and ventral tegmental area of the awake freely moving rat , 2002, Journal of Neuroscience Methods.

[39]  A. Gratton,et al.  Interhemispheric Regulation of the Medial Prefrontal Cortical Glutamate Stress Response in Rats , 2010, The Journal of Neuroscience.

[40]  J. Gidday,et al.  Neurochemical and morphological responses to acutely and chronically implanted brain microdialysis probes , 1998, Journal of Neuroscience Methods.

[41]  E. Wong,et al.  Asenapine Increases Dopamine, Norepinephrine, and Acetylcholine Efflux in the Rat Medial Prefrontal Cortex and Hippocampus , 2008, Neuropsychopharmacology.

[42]  V. Haroutunian,et al.  Altered Vesicular Glutamate Transporter Expression in the Anterior Cingulate Cortex in Schizophrenia , 2008, Biological Psychiatry.

[43]  L. Ferraro,et al.  The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. , 2001, Cerebral cortex.

[44]  D. Finch,et al.  Glutamatergic excitatory responses of anterior cingulate neurons to stimulation of the mediodorsal thalamus and their regulation by GABA: an in vivo iontophoretic study. , 1992, Cerebral cortex.

[45]  T. Jay,et al.  Excitatory Amino Acid Pathway from the Hippocampus to the Prefrontal Cortex. Contribution of AMPA Receptors in Hippocampo‐prefrontal Cortex Transmission , 1992, The European journal of neuroscience.

[46]  P. Goldman-Rakic,et al.  Acetylcholinesterase reactivity in the frontal cortex of human and monkey: Contribution of AChE‐rich pyramidal neurons , 1992, The Journal of comparative neurology.

[47]  P. Kalivas,et al.  Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2003, The Journal of Neuroscience.

[48]  M. Sarter,et al.  Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens , 2002, The European journal of neuroscience.

[49]  Francois Pomerleau,et al.  Improved ceramic-based multisite microelectrode for rapid measurements of l-glutamate in the CNS , 2002, Journal of Neuroscience Methods.

[50]  D. Finch,et al.  Glutamatergic hippocampal formation projections to prefrontal cortex in the rat are regulated by GABAergic inhibition and show convergence with glutamatergic projections from the limbic thalamus , 1994, Hippocampus.

[51]  M. Feenstra,et al.  Monoamine concentrations in rat prefrontal cortex and other mesolimbocortical structures in response to partial neonatal lesions of the medial prefrontal cortex , 1993, Brain Research.

[52]  A. McDonald,et al.  Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: Colocalization of excitatory amino acids and projections to the limbic circuit , 1996, The Journal of comparative neurology.

[53]  G. Rajkowska,et al.  Regional and laminar variations in acetylcholinesterase activity within the frontal cortex of the dog , 1993, Journal of Chemical Neuroanatomy.

[54]  A. Mørk,et al.  Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved , 2009, Psychopharmacology.

[55]  M. Sarter,et al.  Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain , 2001, Brain Research.

[56]  R. Mair,et al.  Lesions of specific and nonspecific thalamic nuclei affect prefrontal cortex-dependent aspects of spatial working memory. , 2005, Behavioral neuroscience.

[57]  P. Henny,et al.  Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons , 2008, The European journal of neuroscience.

[58]  R. Kennedy,et al.  Time-resolved microdialysis for in vivo neurochemical measurements and other applications. , 2008, Annual review of analytical chemistry.

[59]  C. Bradberry,et al.  Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex: Comparison between the Lewis and Fischer 344 rat strains , 1996, Brain Research.

[60]  F. Mora,et al.  Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat , 2008, Neurochemistry International.

[61]  Greg A. Gerhardt,et al.  Second-by-Second Measures of L-Glutamate and Other Neurotransmitters Using Enzyme-Based Microelectrode Arrays , 2007 .

[62]  L. Wilkinson,et al.  Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.

[63]  C. Chiamulera,et al.  Increases in cholinergic neurotransmission measured by using choline-sensitive microelectrodes: Enhanced detection by hydrolysis of acetylcholine on recording sites? , 2008, Neurochemistry International.

[64]  F. Mora,et al.  Amphetamine Increases Extracellular Concentrations of Glutamate in the Prefrontal Cortex of the Awake Rat: A Microdialysis Study , 1998, Neurochemical Research.

[65]  G. Gerhardt,et al.  Second‐by‐second measurement of acetylcholine release in prefrontal cortex , 2006, The European journal of neuroscience.

[66]  Takashi Okuda,et al.  Identification and characterization of the high-affinity choline transporter , 2000, Nature Neuroscience.

[67]  Lawrence K Duffy,et al.  An ultrastructural analysis of tissue surrounding a microdialysis probe , 1999, Journal of Neuroscience Methods.

[68]  J. Cooper,et al.  Acetylation and phosphorylation of choline following high or low affinity uptake by rat cortical synaptosomes , 1982, Neurochemical Research.

[69]  M. Sarter,et al.  D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex , 2007, Neuropharmacology.

[70]  Greg A. Gerhardt,et al.  Age-related changes in glutamate release in the CA3 and dentate gyrus of the rat hippocampus , 2011, Neurobiology of Aging.

[71]  F. Benes,et al.  Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. , 1992, Cerebral cortex.

[72]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[73]  J. Kleinman,et al.  Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.

[74]  M. Fillenz,et al.  The determination of the extracellular concentration of brain glutamate using quantitative microdialysis , 1996, Brain Research.

[75]  A. Romanides,et al.  Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats , 1999, Neuroscience.

[76]  Jane E. Joseph,et al.  Prefrontal cortex and drug abuse vulnerability: Translation to prevention and treatment interventions , 2011, Brain Research Reviews.

[77]  B. Moghaddam,et al.  Effect of a pharmacological stressor on glutamate efflux in the prefrontal cortex , 1996, Brain Research.

[78]  J. Deniau,et al.  An electrophysiological analysis of some afferent and efferent pathways of the rat prefrontal cortex. , 1983, Progress in brain research.

[79]  J. Luthman,et al.  Tissue and microdialysate changes after repeated and permanent probe implantation in the striatum of freely moving rats , 1993, Brain Research Bulletin.

[80]  Francois Pomerleau,et al.  Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex , 2010, Journal of neurochemistry.

[81]  A. Michael,et al.  Electrochemical Methods for Neuroscience , 2006 .

[82]  Larry L. Butcher,et al.  Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis , 1982, Brain Research Bulletin.

[83]  Tsukasa Koyama,et al.  D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex , 2000, Brain Research.

[84]  René Garcia,et al.  Time course of extracellular catecholamine and glutamate levels in the rat medial prefrontal cortex during and after extinction of conditioned fear , 2007, Synapse.

[85]  B. Berger,et al.  Dopaminergic innervation of the rat prefrontal cortex: A fluorescence histochemical study , 1976, Brain Research.

[86]  Natalie Welty,et al.  The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex , 2009, Psychopharmacology.

[87]  G. Burbaeva,et al.  Glutamate Metabolizing Enzymes in Prefrontal Cortex of Alzheimer’s Disease Patients , 2005, Neurochemical Research.